Phase 2
Completed N=30
A Prospective Comparison of Ultrasound-Guided Percutaneous Platelet-Rich Plasma Injection
Tendinosis · Tendinitis
Source: ClinicalTrials.gov NCT01600326 ↗
Enrolled (actual)
30
Serious AEs
3.3%
Results posted
Apr 2017
Primary outcomePrimary: Pain Level and Interference With Activity — 16.8; 25.5; 15.2; 19.4 units on a scale — p=<0.0001
Summary
The purpose of this study is to determine the effectiveness of various treatment soft tendinosis also known as tendinitis.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Pain Level and Interference With Activity |
16.8; 25.5; 15.2; 19.4 | <0.0001 sig |
| SECONDARY Number of Participants Showing Symptomatic Improvement as Assessed in Patient Chart |
10; 11 | >.99 |
Eligibility Criteria
Inclusion Criteria
- Adult subjects with a diagnosis of tendinosis of the hip.
- Adult subjects who have been referred to Dr. Jacobson for the treatment of tendinosis by tenotomy.
Exclusion Criteria
- pregnancy
- risk of bleeding due to anticoagulant medication
- presence of malignancy
- steroid injection less than 3 months before enrollment
Data sourced from ClinicalTrials.gov (NCT01600326). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.